The Food and Drug Administration announced Monday that it will remove black box warnings from hormone replacement therapy products for menopause, reversing a decision made over two decades ago following a Women's Health Initiative study in 2002.
FDA Removes Black Box Warnings From Menopause Hormone Therapy